Patient Data

Exhibits

Which home medication(s) may affect the amount of insulin needed by the client? Select all that apply.

A. Exhibits fewer emotional outbursts: Zolpidem is a sedative-hypnotic medication primarily used to treat insomnia. A reduction in emotional outbursts is not a direct expected outcome of this medication. While improved sleep might indirectly influence mood, it is not the primary therapeutic goal.

B. Decreased episodes of incontinence: Zolpidem's primary action is on the central nervous system to promote sleep. A decrease in episodes of incontinence is not a direct pharmacological effect of zolpidem.

C. Improved ability to concentrate: Zolpidem is a sedative and can potentially cause daytime drowsiness or cognitive impairment rather than improving concentration. Its intended effect is to induce sleep, which could indirectly benefit concentration if the client's difficulty concentrating was due to sleep deprivation, but it's not a direct outcome of the medication itself.

D. Sleeps soundly through the night: The intended therapeutic effect of zolpidem is to help the client initiate and maintain sleep. Documentation stating that the client sleeps soundly through the night indicates that the medication has achieved its desired outcome.

A. Serum liver enzymes: Statins are metabolized in the liver and can cause hepatotoxicity. Baseline liver enzyme levels, such as ALT and AST, should be reviewed before starting statin therapy to ensure the liver is functioning properly and to monitor for potential adverse effects.

B. Serum electrolytes: Electrolytes are important for overall health, but they are not specifically impacted by statin therapy. Reviewing electrolyte levels is not a priority before initiating statins unless other conditions warrant it.

C. Complete blood count: A complete blood count (CBC) provides valuable information about infection or anemia, but it is not directly related to the safety or monitoring of statin medications.

D. Capillary blood glucose: Statins have been associated with a slight risk of elevated blood glucose over long-term use, but an initial capillary blood glucose reading is not required prior to starting therapy. Liver function assessment is the priority.